Peking University Cancer Hospital & Institute: Colorectal Neoplasms trials

The registry lists 16 Colorectal Neoplasms studies with Peking University Cancer Hospital & Institute as lead sponsor. 10 are open to participants now and 0 have results posted.

Phase 2 4Phase 3 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• NOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal CancersNot yet recruitingNCT07775859
• Development and Validation of a Colorectal Cancer Diagnostic ModelNot yet recruitingNCT07692555
• Safety and Efficacy of NOM and OPFS Versus RO for dMMR/MSI-H or POLE-Mutated Gastrointestinal CancersNot yet recruitingNCT07642323
• Evaluating AI and Human Expert Decisions in Colorectal CancerNot yet recruitingNCT07045207
• Efficacy and Safety of DEB-TACE Combined With HAIC Versus HAIC Alone in Patients With Unresectable CRLMNot yet recruitingNCT07031570
• Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver MetastasisNot yet recruitingNCT07007728Phase 2
• A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic TherapyRecruitingNCT06549907
• Hyper-ERAS Program for Highly Selective Colorectal Cancer PatientsRecruitingNCT06256315Not applicable
• KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary CarcinomaNot yet recruitingNCT05985707Phase 2
• KN 046 Plus Regorafenib in MSS Metastatic Colorectal CancerRecruitingNCT05985109Phase 2
• Attitudes and Technical Maneuvers Regarding Enterostomy Management and Stoma Creation Among SurgeonsCompletedNCT06735729
• Dynamic ctDNA Detection for Colorectal Cancer Liver MetastasesCompletedNCT06404593
• PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid TumorStatus unknownNCT05803746Not applicable
• Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line TherapyStatus unknownNCT05406206Phase 2
• Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal CancerStatus unknownNCT04750772Not applicable
• SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer PatientsStatus unknownNCT03448549Phase 3